(1)
Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial. J of Skin 2025, 9 (2), s534. https://doi.org/10.25251/skin.10.supp.534.